This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Nikolaos Bonaros Alfred Kocher Johannes Bonatti Permission Requests Google Scholar Articles by Bonaros, N. Articles by Laufer, G. PubMed PubMed Citation Articles by Bonaros, N. Articles by Laufer, G. Related Collections Coronary disease Molecular biology Myocardial infarction

Neoangiogenesis after combined transplantation of skeletal myoblasts and angiopoietic progenitors leads to increased cell engraftment and lower apoptosis rates in ischemic heart failure

^a Department of Cardiac Surgery, Innsbruck Medical University, Anichstrasse 35, A-6020, Innsbruck, Austria
^b Department of Biochemistry, Innsbruck Medical University, Innsbruck, Austria
^c Department of Cardiothoracic Surgery, Vienna Medical University, Vienna, Austria
^d Department of Transfusion Medicine, Graz Medical University, Austria

*Corresponding author. Tel.: +43 512 504 80764; fax: +43 512 504 22528.

E-mail address: Nikolaos.bonaros{at}i-med.ac.at (N. Bonaros).

Objectives: We previously reported that combined transplantation of skeletal myoblasts and AC-133+ cells leads to improved left ventricular function, reduced infarct size and myocardial apoptosis in a model of chronic ischemia. The aim of this study is to elucidate on the possible mechanisms and to assess new implications in increasing cell therapy efficacy in chronic ischemia. Methods: Heart failure was induced by LAD-ligation in nude rats. (a) Homologous skeletal myoblasts (SM), (b) human derived AC-133+ cells (SC), (c) combination of both cells (Comb) and (d) culture medium (CM) were injected in the infarct and peri-infarct area, respectively, four weeks after infarction. Cell engraftment was detected by fluorescence microscopy and confirmed by immunohistochemical techniques. Cardiac gene expression levels of VEFG-A, cardiac troponin, ACTA2, SDF-1, TGF-beta-1, were assessed by RT-PCR. Results: Both cell types were detected in the injection areas four weeks after cell transplantation. Double cell therapy led to increased cell engraftment (SM: 52±13/mm², SC: 45±8 in the combination group vs. SM: 31±9 and 23±7 in the monotherapy groups, P=0.007). This effect was confirmed using PCR. Apoptotic index among engrafted cells was significantly lower in the Comb group (Comb: 0.53±0.12 for myoblasts and 0.34±0.09 for SC, vs. SM: 0.76±0.19 and SC: 0.63±0.16, P=0.013). Expression of cardiac troponin was higher in the combination group in the peri-infarct area. Evaluation of capillary density revealed increased angiogenesis in the combination group (Comb: 12.3±2.3, SM: 5.2±1.2, SC: 8.3±1.8, P=0.002). Neoangiogenesis was associated with higher levels of VEGF-A and TGF-beta in the injection areas as detected by RT-PCR. The higher SDF-1 expression in the injected areas implies an increased secretion of chemoattractants by the injected cells, which suggests that the effect of combined cell transplantation is mainly associated with paracrine mechanisms. Conclusions: The mechanism of functional improvement after combined transplantation of skeletal myoblasts and AC-133+ progenitors in ischemic heart failure is mainly associated with increased angiogenesis based on paracrine factors, which leads to improved survival and lower apoptosis rates of the injected cells.

Key Words: Myocardial infarction; Ischemic heart failure; Skeletal myoblasts; Stem cell therapy; Angiogenesis